Quantitative analysis for Assembly Biosciences, Inc. (ASMB) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (52.0) (grade C). 30 signals analyzed (24 differentiated alt-data).
ASMB stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $28.21 | $25.97 | $26.33 |
| 2026-05-11 | $30.83 | $28.90 | $30.41 |
| 2026-05-21 | $26.60 | $25.76 | $26.50 |
| 2026-06-03 | $24.65 | $24.00 | $24.57 |
| 2026-06-15 | $24.14 | $23.07 | $23.34 |
| 2026-06-26 | $27.05 | $24.26 | $26.74 |
| 2026-07-09 | $29.24 | $27.63 | $27.87 |
| 2026-07-21 | $26.64 | $24.87 | $26.47 |
| 2026-07-31 | $26.00 | $24.66 | $25.11 |
| 2026-08-12 | $27.39 | $26.74 | $27.06 |
| 2026-08-24 | $36.12 | $33.75 | $35.28 |
| 2026-09-03 | $36.80 | $35.54 | $36.13 |
How Assembly Biosciences, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AUTL | Autolus Therapeutics plc | $431M | 44.0 |
| CGC | Canopy Growth Corporation | $439M | — |
| DBVT | DBV Technologies S.A. | $444M | — |
| OCGN | Ocugen, Inc. | $460M | — |
View all Health Care stocks by valuation and signals →
Assembly Biosciences, Inc. (ASMB) scores Hold (52.0), and the composite conceals a 55-point disagreement between its dimensions. It is strongest on ML forecast at 82 and valuation at 72, and weakest on competitive moat at 27. A stock can carry ML forecast that high while competitive moat sits at 27; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| ML forecast | 82 |
| valuation | 72 |
| technicals | 58 |
| earnings quality | 51 |
| analyst consensus | 45 |
| competitive moat | 27 |
StoQuant analyzes 30 signals (24 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Assembly Biosciences, Inc. (ASMB): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/ASMB"><img src="https://stoquant.com/badge/ASMB.svg" alt="Assembly Biosciences, Inc. (ASMB) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.